Stock
UniQure is breathing a sigh of relief after its controversial gene therapy for Huntington’s disease successfully cleared a critical regulatory hurdle. The company has...
Hi, what are you looking for?
Wall Street experienced a stagnant morning of trading on Wednesday as investors grappled with a volatile mix of geopolitical tension and conflicting economic signals....
UniQure is breathing a sigh of relief after its controversial gene therapy for Huntington’s disease successfully cleared a critical regulatory hurdle. The company has...
Swiss banking giant UBS has downgraded its outlook on the Spanish construction firm Ferrovial, shifting the stock from a buy to neutral following the...